Synthesis of novel S-acyl and S-alkylpyrimidinone derivatives as potential cytotoxic agents
dc.Affiliation | October University for modern sciences and Arts (MSA) | |
dc.contributor.author | Said M.M. | |
dc.contributor.author | Taher A.T. | |
dc.contributor.author | El-Nassan H.B. | |
dc.contributor.author | El-Khouly E.A. | |
dc.contributor.other | Pharmaceutical Organic Chemistry Department | |
dc.contributor.other | Faculty of Pharmacy | |
dc.contributor.other | Cairo University | |
dc.contributor.other | 33 Kasr El-Aini Street | |
dc.contributor.other | Cairo | |
dc.contributor.other | 11562 | |
dc.contributor.other | Egypt; Organic chemistry Department | |
dc.contributor.other | Faculty of Pharmacy | |
dc.contributor.other | October University for Modern Sciences and Arts (MSA) | |
dc.contributor.other | Giza | |
dc.contributor.other | Egypt | |
dc.date.accessioned | 2020-01-09T20:41:36Z | |
dc.date.available | 2020-01-09T20:41:36Z | |
dc.date.issued | 2016 | |
dc.description | Scopus | |
dc.description.abstract | Abstract: Two series of 4-phenyl-5-cyanopyrimidin-6-one derivatives bearing various S-alkyl or S-acyl moieties at position 2 were prepared as cytotoxic agents. All compounds were tested for possible anti-cancer activity on two cell lines (MCF-7 and HCT-116). The MCF-7 cell line was found to be more sensitive than the HCT-116 cell line to the action of the compounds. Compound 8g was the most potent on the MCF-7 cell line with IC50 18.3�nM/mL, whereas its IC50 on the normal cell line (MRC-5) was 64.38�nM/mL, indicating its safety and selectivity towards the MCF-7 cell line. On the other hand, compound 8d was the most potent compound on the HCT-116 cell line with IC50 23.8�nM/mL. Compound 8g was screened against five kinases. The compound showed selective inhibitory activity against pim1 kinase with IC50 11.62��M. Graphical Abstract: [Figure not available: see fulltext.] � 2016, Springer Science+Business Media Dordrecht. | en_US |
dc.description.uri | https://www.scimagojr.com/journalsearch.php?q=21492&tip=sid&clean=0 | |
dc.identifier.doi | https://doi.org/10.1007/s11164-016-2487-x | |
dc.identifier.doi | PubMed ID : | |
dc.identifier.issn | 9226168 | |
dc.identifier.other | https://doi.org/10.1007/s11164-016-2487-x | |
dc.identifier.other | PubMed ID : | |
dc.identifier.uri | https://t.ly/2dre5 | |
dc.language.iso | English | en_US |
dc.publisher | Springer Netherlands | en_US |
dc.relation.ispartofseries | Research on Chemical Intermediates | |
dc.relation.ispartofseries | 42 | |
dc.subject | Antitumor activity | en_US |
dc.subject | HCT-116 | en_US |
dc.subject | MCF-7 | en_US |
dc.subject | pim1 | en_US |
dc.subject | Pyrimidine | en_US |
dc.subject | Cell culture | en_US |
dc.subject | Cytology | en_US |
dc.subject | Enzymes | en_US |
dc.subject | Anti-tumor activities | en_US |
dc.subject | HCT-116 | en_US |
dc.subject | MCF-7 | en_US |
dc.subject | pim1 | en_US |
dc.subject | Pyrimidine | en_US |
dc.subject | Cells | en_US |
dc.title | Synthesis of novel S-acyl and S-alkylpyrimidinone derivatives as potential cytotoxic agents | en_US |
dc.type | Article | en_US |
dcterms.isReferencedBy | (2015) JAMA Oncol., 1, p. 505; Bixby, D., Talpaz, M., (2010) Leukemia, 25, p. 7; Palasz, A., Ciez, D., (2014) Eur. J. Med. Chem., 97, p. 582; Fargualy, A.M., Habib, N.S., Ismail, K.A., Hassan, A.M.M., Sarg, M.T.M., (2013) Eur. J. Med. Chem., 66, p. 276. , COI: 1:CAS:528:DC%2BC3sXht1SktbjM; Mai, A., Perrone, A., Nebbioso, A., Rotili, D., Valente, S., Tardugno, M., Massa, S., Altucci, L., (2008) Bioorg. Med. Chem. Lett., 18, p. 2530. , COI: 1:CAS:528:DC%2BD1cXks1aksb4%3D; Abdel-Mohsen, H.T., Ragab, F.A.F., Ramla, M.M., El Diwani, H.I., (2010) Eur. J. Med. Chem., 45, p. 2336. , COI: 1:CAS:528:DC%2BC3cXkvFeisLs%3D; Taher, A.T., Abou-Seri, S.M., (2012) Molecules, 17, p. 9868. , COI: 1:CAS:528:DC%2BC38Xht1KhsbnM; Chen, P.-J., Yang, A., Gu, Y.-F., Zhang, X.-S., Shao, K.-P., Xue, D.-Q., He, P., Liu, H.-M., (2014) Bioorg. Med. Chem. Lett., 24, p. 2741. , COI: 1:CAS:528:DC%2BC2cXntlyjs78%3D; Shao, K.-P., Zhang, X.-Y., Chen, P.-J., Xue, D.-Q., He, P., Ma, L.-Y., Zheng, J.-X., Liu, H.-M., (2014) Bioorg. Med. Chem. Lett., 24, p. 3877. , COI: 1:CAS:528:DC%2BC2cXhtFWnsL3J; Ramiz, M.M.M., El-Sayed, W.A., Hagag, E., Abdel-Rahman, A.A.H., (2011) J. Heterocycl. Chem., 48, p. 1028. , COI: 1:CAS:528:DC%2BC3MXht1Wku7%2FL; Rajak, H., Kumar, P., Parmar, P., Thakur, B.S., Veerasamy, R., Sharma, P.C., Sharma, A.K., Dangi, J.S., (2012) Eur. J. Med. Chem., 53, p. 390. , COI: 1:CAS:528:DC%2BC38XnvVygt7o%3D; Harvill, E.K., Herbst, R.M., Schreiner, E.G., (1952) J. Org. Chem., 17, p. 1597. , COI: 1:CAS:528:DyaG2cXnt1Sh; Unger, Y., Strassner, T., (2012) J. Organomet. Chem., 713, p. 203. , COI: 1:CAS:528:DC%2BC38XptF2gur8%3D; Sakurai, G., Matsui, E., (1965) Chem. Pharm. Bull., 13, p. 594. , COI: 1:CAS:528:DyaF2MXktlWltLc%3D; Dalalian, H.P., Rutherford, N.J., (1957) S. Kushner, U.S. patent, 2,807, p. 617; Ganguly, S., Vishwanathan, R., Chandra, R., (2009) J. Inst. Chem., 81, p. 57. , COI: 1:CAS:528:DC%2BD1MXhsVagtbbO; Devegowda, V.N., Seo, S.H., Pae, A.N., Nam, G., Choi, K.I., (2012) Bull. Korean Chem. Soc., 33, p. 647. , COI: 1:CAS:528:DC%2BC38XktFOmu7w%3D; Skehan, P., Storeng, R., Scudiero, D., Monks, A., McMahon, J., Vistica, D., Warren, J.T., Boyd, M.R., (1990) J. Natl Cancer Inst., 82, p. 1107. , COI: 1:CAS:528:DyaK3cXltVylsL8%3D; Xia, Z., Knaak, C., Ma, J., Beharry, Z.M., McInnes, C., Wang, W., Kraft, A.S., Smith, C.D., (2009) J. Med. Chem., 52, p. 74. , COI: 1:CAS:528:DC%2BD1cXhsFSjur%2FM; Uehara, F., Shoda, A., Aritomo, K., Fukunaga, K., Watanabe, K., Ando, R., Shinoda, M., Niwa, T., (2013) Bioorg. Med. Chem. Lett., 23, p. 6928. , COI: 1:CAS:528:DC%2BC3sXhsFynu7%2FL; Al-Suwaidan, I.A., Alanazi, A.M., Abdel-Aziz, A.A.-M., Mohamed, M.A., El-Azab, A.S., (2013) Bioorg. Med. Chem. Lett., 23, p. 3935. , COI: 1:CAS:528:DC%2BC3sXnvV2kurs%3D; Chatterjee, A., Cutler, S.J., Doerksen, R.J., Khan, I.A., Williamson, J.S., (2014) Bioorg. Med. Chem., 22, p. 6409. , COI: 1:CAS:528:DC%2BC2cXhs1yls7vK; Drygin, D., Haddach, M., Pierre, F., Ryckman, D.M., (2012) J. Med. Chem., 55, p. 8199. , COI: 1:CAS:528:DC%2BC38Xht1OmtL7J; Nawijn, M.C., Alendar, A., Berns, A., (2011) Nat. Rev. Cancer, 11, p. 23. , COI: 1:CAS:528:DC%2BC3cXhsFCjsrjE; Merke, A.L., Meggers, E., Ocker, M., (2012) Expert Opin. Investig. Drugs, 21, p. 425; Morwick, T., (2010) Exp. Opin. Ther. Patents, 20, p. 193. , COI: 1:CAS:528:DC%2BC3cXhtVGktbg%3D; Arunesh, G.M., Shanthi, E., Krishna, M.H., Kumar, J.S., Viswanadhan, V.N., (2014) Exp. Opin. Ther. Patents, 24, p. 5. , COI: 1:CAS:528:DC%2BC3sXhvFSlurvM; Inc. 6-Phenylpyrimidinones as Pim modulators (2008) WO2008133955 | |
dcterms.source | Scopus |